Searchable abstracts of presentations at key conferences in endocrinology

ea0063p941 | Diabetes, Obesity and Metabolism 3 | ECE2019

Increased serum resistin levels in metabolically unhealthy compared to metabolically healthy obese individuals; correlation with circulating white blood cell subpopulations

Christou Konstantinos , Christou Georgios , Karamoutsios Achilleas , Vartholomatos Georgios , Gartzonika Konstantina , Tsatsoulis Agathocles , Tigas Stelios

Background: Obesity is associated with chronic low-grade inflammation that contributes to the development of metabolic syndrome (MS). Resistin, produced by neutrophils and monocytes, displays potent proinflammatory properties and has been associated with cardiometabolic disease. The aim of this study was to (a) determine serum resistin levels among obese patients with or without MS and (b) explore the role of the subsets of circulating white blood cells as potential determinan...

ea0037ep1143 | Endocrine tumours | ECE2015

A case series of etomidate use in ACTH ectopic syndrome in endocrine neoplasms

Boutzios Georgios , Nikolopoulos Georgios , Alexandraki Krystallenia , Kaltsatou Maria , Chrysochoou Maria , Tsoli Marina , Kaltsas Gregory

Introduction: Etomidate is an imidazole derivative which inhibits several enzymatic steps (11β-hydroxylasey, 17β-hydroxylase, 17,20-lyase, cholesterol side-chain cleavage). Intravenous etomidate at sub-anaesthetic doses remains an important option when i.v. administration is required for rapid treatment of severely ill patients with hypercortisolaemia (Cushing’s syndrome, CS) and is almost always very effective.Case series: A 49-year-old w...

ea0016p94 | Bone and calcium | ECE2008

Scintigraphic, biochemical and clinical response to zoledronic acid treatment in patients with Paget's disease of bone

Avramidis Avraam , Polyzos Stergios , Moralidis Efstratios , Arsos Georgios , Efstathiadou Zoe , Karakatsanis Konstantinos , Grollios Georgios , Kita Marina

Introduction: Bisphosponates have long been used with success in the treatment of Paget’s disease of bone (PDB). The aim of this study was to evaluate the early (up to three months) and late (at twelve months) scintigraphic, biochemical and clinical response to a single intravenous infusion of zoledronic acid (ZOL) in patients with PDB serially assessed for one year.Materials and methods: Nine patients with 30 bone lesions due to PDB were prospectiv...

ea0056p137 | Endocrine tumours and neoplasia | ECE2018

Unraveling the incidence and clinical patterns of neuroendocrine neoplasms in Greece, through the experience of multipotent, specialized clinical centers.

Papalou Olga , Kandaraki Eleni , Papadakis Georgios , Nikou Georgios , Diamanti-Kandarakis Evanthia

Introduction: Neuroendocrine neoplasms (NENs) are a heterogeneous group of tumors arising from neuroendocrine cells in the endocrine and central nervous system, the natural history of which remains inadequately understood. Large epidemiological studies are gradually emerging from different countries worldwide, which contribute to the establishment of a spherical view about these tumors. The purpose of this study is to evaluate the epidemiological, clinical and pathological cha...

ea0081p467 | Thyroid | ECE2022

Vitamin D levels in patients with graves orbitopathy

Boutzios Georgios , Chatzi Sofia , Mina Areti , Koukoulioti Eleni , Tzioufas Athanasios

Introduction: Graves’ disease (GD) is an autoimmune thyroiditis frequently associated with development of Graves’ orbitopathy (GO). GD patients have lower vitamin D levels compared to the general population. Whether low vitamin D levels are associated with GO is still controversial. The aim of our study was to assess the vitamin D levels in patients with GO and the clinical outcome.Methods: This is a single-center observational study in an outp...

ea0086p108 | Neuroendocrinology and Pituitary | SFEBES2022

Dopamine agonist intolerance in prolactinoma- A management challenge to endocrinologist

Wellala Vindya , Machenahalli Pratibha , Kumarathunga Dineesha , Georgios Giovos , Puja Thadani

Introduction: Typically, patients with a microprolactinoma will have serum prolactin level between 2,000-4,000mIU/l. The primary goal of treatment is to normalise prolactin level and thereby improve symptoms associated with a raised prolactin. Dopamine (D2) agonists are the main stay of treatment with some patients unable to tolerate dopamine agonists rather than being resistant to the medication.Case report: A 26-year-old lady with a history of anxiety ...

ea0090ep1109 | Late Breaking | ECE2023

Design and development of mobile application for type 2 diabetes ‘Diabetes 2 Learn’

Lykoudi Elissavet , Lymperopoulos Georgios , Dokoutsidou Eleni , Vlachou Eugenia , Margari Nikoletta

Introduction: Worldwide, diabetes is a common metabolic disorder that creates many complications. Nowadays a mobile-based application could be included in the therapeutic approaches of self-management.Aim: This study presents the development of a mobile application named ‘Diabetes 2 Learn’ for people with type 2 diabetes inside the Greek population.Methods: Google Play and App Store were examined for their apps on diabete...

ea0091cb13 | Additional Cases | SFEEU2023

Persistent Hyperthyroidism Secondary to Ectopic Autonomous Thyroid Tissue

Subbiah Kasi , Khalilova Samira , Sathyanarayan Sheela , Dimitriadis Georgios

A 28 year old lady presented with a 4 month history of anxiety, palpitations, weight loss and a pressure sensation in the neck. On examination she had fine tremor of her outstretched fingers and no palpable goitre with a regular heart rate. FT4 was 22 pmol/l(10.3-24.5), FT3 7.9 pmol/l(3.5-6.5), TSH 0.02 mIU/l(0.3-5.5), TSH receptor antibodies (TRAb) <0.9 U/l(0-1.75) and TPO antibodies <4 IU/ml (0-35). She was started on Carbimazole 20 mg daily and after being well cont...

ea0091cb54 | Additional Cases | SFEEU2023

Complexities in the diagnosing of Cushing’s syndrome

Wellala Vindya , Ranganatha Rao , Kumarathunga Dineesha , Thadani Puja , Georgios Giovos

Diagnosis of Cushing’s syndrome is challenging in the absence of cardinal features. But still, they have the same metabolic risk due to the presence of biochemical hypercortisolism. A 35-year lady was referred to the tertiary care endocrine unit following an incidental finding of high cortisol levels while on treatment for covid in 2021. She also had some weight gain, slow healing of wounds, and easy bruising. She did not have any features of hyperandrogenism and hyperten...

ea0065p287 | Neuroendocrinology | SFEBES2019

Cannulated prolactin as a diagnostic tool for true hyperprolactinaemia

Machenahalli C Pratibha , Giovos Georgios , Randeva Harpal , Smith Megan

Background: Hyperprolactinaemia is the common endocrine disorders. More commonly diagnosed in women due to menstrual irregularity, infertility and galactorrhoea. Hyperprolactinaemia can be due to many physiological stimuli such as stress, sleep, exercise, medications, primary hypothyroidism, renal failure, chest wall lesion. Stress of venepuncture can contribute to hyperprolactinaemia as well.Patient and methods: We conducted a retrospective analysis of ...